On Dec. 16, the U.S. Food and Drug Administration cleared the da Vinci Surgical System® for benign and malignant tumors in such locations as the tongue, tonsils, mouth and voice box. Studies have found that, compared with conventional surgical techniques, the robotic system can result in shorter hospital stays, fewer complications, less blood loss and… Continue reading